H2020FP7HORIZON
Universitair Medisch Centrum Utrecht
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 295
- As coordinator
- 121
- EU contribution (CORDIS)
- EUR 267,199,815
- Active
- 2008 to 2025
Projects
295 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MDDANEURODEVMolecular coding and subset specification of dopamine neurons generating the the meso-limbic and nigro-striatal system | FP7 | 2009 | Coordinator | EUR 750,937 |
| NEMOTreatment of NEonatal seizures with Medication Off-patent: evaluation of efficacy and safety of bumetanide | FP7 | 2009 | Participant | EUR 307,362 |
| CHEARTEDGene- Environment Interactions in Heart Development | FP7 | 2009 | Participant | EUR 45,000 |
| EUTRIGTREATIdentification and therapeutic targeting of common arrhythmia trigger mechanisms | FP7 | 2009 | Participant | EUR 620,000 |
| CHAINCollaborative HIV and Anti-HIV Drug Resistance Network | FP7 | 2009 | Participant | EUR 39,150 |
| MECHWNTSIGNALSMechanisms of Wnt Signaling Initiation | FP7 | 2009 | Coordinator | EUR 1,513,800 |
| MITOTARGETMitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics | FP7 | 2009 | Participant | Not stated |
| EUSTROKEEuropean Stroke Research Network | FP7 | 2008 | Participant | EUR 676,800 |
| MOODINFLAMEEarly diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system | FP7 | 2008 | Participant | EUR 123,395 |
| FASTTOWARDS SAFE AND EFFECTIVE IMMUNOTHERAPY OF PERSISTENT LIFE-THREATENING FOOD ALLERGIES | FP7 | 2008 | Participant | EUR 63,070 |
| NOTCH PROTEOLYSISTargeting the Notch Protease Interface | FP7 | 2008 | Participant | EUR 297,164 |
| MIRSURGMid-Infrared Solid-State Laser Systems for Minimally Invasive Surgery | FP7 | 2008 | Participant | EUR 175,650 |
| HANDOVERImproving the Continuity of patient care Through Identification and implementation of Novel patient handoff processes in Europe | FP7 | 2008 | Coordinator | EUR 676,800 |
| COPACETICCOPD Pathology: Addressing Critical gaps, Early Treatment and Innovative Concepts | FP7 | 2008 | Coordinator | EUR 512,900 |
| SONODRUGSImage-controlled Ultrasound-induced Drug Delivery | FP7 | 2008 | Participant | EUR 476,066 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.